AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glifab 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Biomorph Lifesciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glifab 2mg/500mg Tablet SR

Glifab SR tablets (2mg/500mg) are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Administer Glifab SR with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical guidance can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is a component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential for prevention. Alcohol consumption should be limited due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may also occur. Glifab SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests assessing blood cell counts and liver function, are recommended.

Uses of Glifab 2mg/500mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Glifab 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not crush, chew, or break it. Glifab 2mg/500mg Sustained-Release tablets should be taken with a meal.

Common Side effects of Glifab 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glifab 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. It is recommended to take the Glifab 2mg/500mg Sustained-Release tablet with food.

How Glifab 2mg/500mg Tablet SR works:

Glifab SR tablets (2mg glimepiride/500mg metformin) combine two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glifab 2mg/500mg SR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glifab 2mg/500mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glifab tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glifab 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Glifab 2mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glifab 2mg/500mg SR tablets cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease should typically begin with a low dose; however, Glifab 2mg/500mg SR tablets are contraindicated in those with severe hepatic dysfunction. Medical advice is recommended.

What if you forget to take Glifab 2mg/500mg Tablet SR :

Should you forget a Glifab 2mg/500mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glifab 2mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Diabetes medication

FAQs on Glifab 2mg/500mg Tablet SR

Always keep this medication in its original, tightly sealed container. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Glifab 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in patients with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms may include muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. If any of these symptoms occur, discontinue Glifab 2mg/500mg Tablet SR and seek immediate medical attention.
Glimepiride/Metformin 2mg/500mg extended-release tablets (Glifab) combine two diabetes medications to manage type 2 diabetes mellitus in adults. This therapy enhances blood sugar control when used with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and increases insulin responsiveness. This combination is unsuitable for type 1 diabetes.
Glifab 2mg/500mg sustained-release tablets may cause common adverse reactions including low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious side effects such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 deficiency.
Prolonged Glifab 2mg/500mg SR tablet use can indeed lead to Vitamin B12 deficiency by hindering its gastric absorption. This deficiency, if left unaddressed, may manifest as anemia, neurological issues including peripheral paresthesia (tingling and numbness in the extremities), weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures suggested by some studies involve supplemental Vitamin B12 intake at least annually.
Indeed, taking Glifab 2mg/500mg Extended-Release tablets may lead to hypoglycemia (low blood glucose). Low blood sugar can manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, rapid heartbeat, and feelings of unease or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glifab 2mg/500mg SR tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raises the risk of lactic acidosis.
Glifab 2mg/500mg Tablet S...
62
MRP 75
17% off